Halperin SA - Search Results

1

Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.

Ricketson LJ, Bettinger JA, Sadarangani M, Halperin SA, Kellner JD; Canadian Immunization Monitoring Program, Active (IMPACT) Investigators. Ricketson LJ, et al. Among authors: halperin sa. Vaccine. 2022 Apr 26;40(19):2733-2740. doi: 10.1016/j.vaccine.2022.03.048. Epub 2022 Mar 26. Vaccine. 2022. PMID: 35351324 Free article.

2

Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998.

Bjornson GL, Scheifele DW, Halperin SA; Canadian Paediatric Society/Health Canada Immunization Monitoring Program, Active. Bjornson GL, et al. Among authors: halperin sa. Pediatr Infect Dis J. 2002 Oct;21(10):947-50. doi: 10.1097/00006454-200210000-00012. Pediatr Infect Dis J. 2002. PMID: 12394818

3

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

4

A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial.

Langley JM, Halperin SA, Smith B. Langley JM, et al. Among authors: halperin sa. Vaccine. 2003 Sep 8;21(25-26):3863-6. doi: 10.1016/s0264-410x(03)00304-9. Vaccine. 2003. PMID: 12922120 Clinical Trial.

5

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

Halperin SA, Dobson S, McNeil S, Langley JM, Smith B, McCall-Sani R, Levitt D, Nest GV, Gennevois D, Eiden JJ. Halperin SA, et al. Vaccine. 2006 Jan 9;24(1):20-6. doi: 10.1016/j.vaccine.2005.08.095. Epub 2005 Sep 12. Vaccine. 2006. PMID: 16198027 Clinical Trial.

6

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

Scheifele DW, Halperin SA, Smith B, Ochnio J, Meloff K, Duarte-Monteiro D. Scheifele DW, et al. Among authors: halperin sa. Vaccine. 2006 Mar 15;24(12):2057-64. doi: 10.1016/j.vaccine.2005.11.021. Epub 2005 Nov 28. Vaccine. 2006. PMID: 16356598 Clinical Trial.

7

Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers.

Halperin SA, Tapiero B, Law B, Diaz-Mitoma F, Duval B, Langley JM, Elrick DB, Jacquet JM. Halperin SA, et al. Vaccine. 2006 May 1;24(18):4017-23. doi: 10.1016/j.vaccine.2005.11.012. Epub 2005 Nov 21. Vaccine. 2006. PMID: 16516357 Clinical Trial.

8

An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.

Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA. Langley JM, et al. Among authors: halperin sa. Vaccine. 2007 Jan 22;25(6):1121-5. doi: 10.1016/j.vaccine.2006.09.053. Epub 2006 Oct 2. Vaccine. 2007. PMID: 17045366 Clinical Trial.

9

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults.

Halperin SA, Langley JM, Smith B, Wunderli P, Kaufman L, Kimura A, Martin D. Halperin SA, et al. Vaccine. 2007 Jan 5;25(3):450-7. doi: 10.1016/j.vaccine.2006.08.001. Epub 2006 Aug 10. Vaccine. 2007. PMID: 17052819 Clinical Trial.

10

The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.

Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T. Bettinger JA, et al. Among authors: halperin sa. Pediatr Infect Dis J. 2007 Jan;26(1):31-5. doi: 10.1097/01.inf.0000247055.81541.04. Pediatr Infect Dis J. 2007. PMID: 17195702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page